Key regions: Europe, Germany, Canada, Japan, South Korea
The OTC Products (Pharmacies) market in Brazil has been experiencing significant growth in recent years.
Customer preferences: Brazilian consumers have shown a growing preference for over-the-counter (OTC) products, which can be attributed to several factors. Firstly, there is an increasing awareness and emphasis on self-care and preventive healthcare among the population. Consumers are becoming more proactive in managing their health and are seeking accessible and convenient solutions for common ailments. OTC products provide a convenient and cost-effective option for treating minor illnesses and symptoms without the need for a prescription. Furthermore, the rise of e-commerce has made it easier for consumers to access a wide range of OTC products. Online platforms offer a convenient and discreet way to purchase these products, eliminating the need to visit physical pharmacies. This has particularly appealed to younger consumers who are tech-savvy and prefer the convenience of online shopping.
Trends in the market: One key trend in the OTC Products market in Brazil is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking natural alternatives to traditional pharmaceuticals. This trend is driven by a desire for more sustainable and environmentally friendly options, as well as a growing interest in holistic health and wellness. Another trend in the market is the expansion of product offerings to cater to specific consumer needs. Pharmacies are increasingly stocking a wider range of OTC products, including specialized products for different age groups, genders, and health conditions. This trend reflects the growing understanding that different consumers have unique needs and preferences, and that a one-size-fits-all approach is no longer sufficient.
Local special circumstances: Brazil has a large population with a diverse range of healthcare needs. The country's healthcare system is characterized by a mix of public and private providers, with a significant portion of the population relying on the public system. This has created a demand for affordable healthcare solutions, including OTC products. The availability and accessibility of OTC products in pharmacies across the country make them a popular choice for many Brazilians. Additionally, the Brazilian government has implemented policies to promote the use of generic drugs, including OTC products. This has led to increased competition in the market, driving down prices and making OTC products more affordable for consumers.
Underlying macroeconomic factors: The OTC Products market in Brazil is influenced by several macroeconomic factors. The country has experienced economic growth in recent years, with a rising middle class and increased purchasing power. This has contributed to increased consumer spending on healthcare products, including OTC products. Furthermore, Brazil has a rapidly aging population, which is driving demand for healthcare products and services. As the population ages, there is a greater need for OTC products to manage chronic conditions and age-related health issues. This demographic trend is expected to continue in the coming years, further fueling the growth of the OTC Products market. In conclusion, the OTC Products market in Brazil is experiencing growth due to changing customer preferences, including a preference for self-care and preventive healthcare. The market is also influenced by trends such as the demand for natural remedies and the expansion of product offerings. Local special circumstances, such as the diverse healthcare needs of the population and government policies promoting the use of generic drugs, further contribute to the market's development. Underlying macroeconomic factors, such as economic growth and an aging population, are also driving the growth of the OTC Products market in Brazil.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
